n-(Cyclopropylmethyl)benzo[d][1,3]dioxol-5-amine, 95%, 250mg

4-[(2,6-dichlorobenzyl)oxy]-3-ethoxybenzaldehyde, 250mg

2,2,3,3-Tetrafluoro-1-propanol>98.0%(GC)500g

(2-Bromo-4,5-dimethoxyphenoxy)trimethylsilane>96.0%(GC)1g

trans-4-(6,8-dibromo-1,2-dihydroquinazolin-3(4H)-yl)cyclohexanol hydrochloride, 95.0%, 250mg

ethyl 5-(2-methylphenyl)-1H-pyrazole-3-carboxylate, 95.0%, 1g

[(2-methylcyclopentyl)methyl]amine hydrochloride, 95.0%, 250mg

(1R,2R,4R)-rel-1-Azabicyclo[2,2,1]heptane-2-carboxylic acid hydrochloride, 95%, 100mg

N-(3,4-Dimethoxyphenyl)-4-methylbenzenesulfonamide, 95%, 5g

4-Methyl-2-pyrrolidinone, 95.0%, 10g

3-(3-Methyl-3H-diazirin-3-yl)-N-((2S,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl)propanamide, 97%, 1g

4-[(E)-(4-methoxyphenyl)diazenyl]benzene-1,3-diamine, 85.0%, 1g

Bis(2-ethylhexyl) isophthalate, 98%, 25g